E. O's most recent trade in Washington Trust Bancorp, Inc. was a trade of 6,848 Common Stock done . Disclosure was reported to the exchange on April 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Washington Trust Bancorp Inc | Edward O. Handy | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2026 | 6,848 | 51,351 (0%) | 0% | 0 | Common Stock | |
| Washington Trust Bancorp Inc | Edward O. Handy | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.16 per share. | 06 Apr 2026 | 3,104 | 48,247 (0%) | 0% | 34.2 | 106,033 | Common Stock |
| Banner Corp | Daniel Everett Oxford | Executive VP, Banner Bank | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.86 per share. | 02 Apr 2026 | 103 | 9,308 (0%) | 0% | 60.9 | 6,269 | Common Stock, $0.01 par value per share |
| Altice USA Inc (Class A) | Michael E. Olsen | General Counsel and CCRO | Sale of securities on an exchange or to another person at price $ 1.29 per share. | 01 Apr 2026 | 20,000 | 1,219,781 (0%) | 0% | 1.3 | 25,800 | Class A common stock |
| Hewlett Packard | Raymond E. Ozzie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.98 per share. | 01 Apr 2026 | 14,500 | 176,400 (0%) | 0% | 24.0 | 347,710 | Common Stock |
| Hewlett Packard | Raymond E. Ozzie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 14,500 | 0 | - | - | Restricted Stock Units | |
| Banner Corp | Daniel Everett Oxford | Executive VP, Banner Bank | Grant, award, or other acquisition of securities at price $ 61.40 per share. | 01 Apr 2026 | 1,986 | 9,626 (0%) | 0% | 61.4 | 121,940 | Common Stock, $0.01 par value per share |
| Banner Corp | Daniel Everett Oxford | Executive VP, Banner Bank | Grant, award, or other acquisition of securities at price $ 61.40 per share. | 01 Apr 2026 | 1,324 | 7,640 (0%) | 0% | 61.4 | 81,294 | Common Stock, $0.01 par value per share |
| Southern Co | James O. Etheredge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2026 | 464 | 2,389 | - | - | Deferred Stock Units Holding | |
| Bank of New York Mellon | Sandra E. O’Connor | Director | Grant, award, or other acquisition of securities at price $ 121.15 per share. | 01 Apr 2026 | 227 | 6,899 (0%) | 0% | 121.1 | 27,500 | Common Stock |
| Banner Corp | Daniel Everett Oxford | Executive VP, Banner Bank | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.34 per share. | 01 Apr 2026 | 137 | 9,489 (0%) | 0% | 61.3 | 8,404 | Common Stock, $0.01 par value per share |
| Banner Corp | Daniel Everett Oxford | Executive VP, Banner Bank | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.35 per share. | 01 Apr 2026 | 78 | 9,411 (0%) | 0% | 61.3 | 4,785 | Common Stock, $0.01 par value per share |
| CPI Card Group Inc | Margaret Elizabeth O'Leary | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 13,922 | 13,922 | - | - | Phantom Stock | |
| CPI Card Group Inc | Margaret Elizabeth O'Leary | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 3,791 | 3,791 | - | - | Restricted Stock Units | |
| Iridium Comm Inc | Eric T. Olson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 756 | 157,295 (0%) | 0% | 0 | Common Stock | |
| CPI Card Group Inc | Margaret Elizabeth O'Leary | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 633 | 27,765 (0%) | 0% | - | Common Stock | |
| CPI Card Group Inc | Margaret Elizabeth O'Leary | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2026 | 633 | 1,264 | - | - | Restricted Stock Units | |
| Modular Medical Inc | Ellen O'Connor Vos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 250 | 250 | - | - | Option to purchase common stock | |
| CPI Card Group Inc | Margaret Elizabeth O'Leary | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.51 per share. | 31 Mar 2026 | 182 | 27,583 (0%) | 0% | 14.5 | 2,641 | Common Stock |
| CPI Card Group Inc | Margaret Elizabeth O'Leary | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2026 | 970 | 970 | - | - | Restricted Stock Units | |
| CPI Card Group Inc | Margaret Elizabeth O'Leary | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2026 | 970 | 27,411 (0%) | 0% | - | Common Stock | |
| CPI Card Group Inc | Margaret Elizabeth O'Leary | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.19 per share. | 29 Mar 2026 | 279 | 27,132 (0%) | 0% | 14.2 | 3,959 | Common Stock |
| Burford Cap Ltd | Elizabeth O’Connell | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2026 | 18,437 | 53,191 | - | 0 | Ordinary shares, no par value ("Ordinary Shares") | |
| Burford Cap Ltd | Elizabeth O’Connell | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2026 | 18,437 | 407,033 | - | - | RSUs | |
| Burford Cap Ltd | Elizabeth O’Connell | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2026 | 14,197 | 392,836 | - | - | PSUs | |
| Burford Cap Ltd | Elizabeth O’Connell | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2026 | 14,197 | 67,388 | - | 0 | Ordinary Shares | |
| Burford Cap Ltd | Elizabeth O’Connell | Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.70 per share. | 26 Mar 2026 | 13,029 | 54,359 | - | 7.7 | 100,323 | Ordinary Shares |
| Burford Cap Ltd | Elizabeth O’Connell | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2026 | 3,791 | 389,045 | - | - | RSUs | |
| Burford Cap Ltd | Elizabeth O’Connell | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 3,791 | 392,836 | - | - | Phantom RSUs | |
| Choice Hotels Intl Inc | Scott E. Oaksmith | SVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 17 Mar 2026 | 1,603 | 37,172 (0%) | 0% | 100 | 160,300 | Common Stock |
| Choice Hotels Intl Inc | Scott E. Oaksmith | SVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 100.07 per share. | 17 Mar 2026 | 600 | 38,775 (0%) | 0% | 100.1 | 60,042 | Common Stock |
| Enovis Corp | Oliver Engert | Chief Administrative Officer | Purchase of securities on an exchange or from another person at price $ 23.74 per share. | 13 Mar 2026 | 1,000 | 48,640 (0%) | 0% | 23.7 | 23,740 | Common stock, par value $0.001 |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 225.00 per share. | 11 Mar 2026 | 3,057 | 21,010 (0%) | 0% | 225 | 687,825 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2026 | 2,405 | 0 | - | - | Employee Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 92.65 per share. | 11 Mar 2026 | 2,405 | 24,067 (0%) | 0% | 92.6 | 222,823 | Common Stock |
| BlackSky Tech Inc (Class A) | Brian E. O'Toole | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 191,666 | 1,155,188 | - | 0 | Class A Common Stock | |
| BlackSky Tech Inc (Class A) | Brian E. O'Toole | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.00 per share. | 10 Mar 2026 | 24,999 | 963,522 | - | 24 | 599,976 | Class A Common Stock |
| Nelnet Inc (Class A) | Emily R. Olinger | Chief People Services Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 2,258 | 6,636 (0%) | 0% | 0 | Class A Common Stock | |
| Nelnet Inc (Class A) | Emily R. Olinger | Chief People Services Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 1,732 | 8,368 (0%) | 0% | 0 | Class A Common Stock | |
| Enovis Corp | Oliver Engert | Chief Administrative Officer | Purchase of securities on an exchange or from another person at price $ 23.93 per share. | 10 Mar 2026 | 1,000 | 47,640 (0%) | 0% | 23.9 | 23,930 | Common stock, par value $0.001 |
| NetApp | Elizabeth M. O'Callahan | EVP, Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 100.67 per share. | 10 Mar 2026 | 1,000 | 20,382 (0%) | 0% | 100.7 | 100,670 | Common Shares |
| Nelnet Inc (Class A) | Emily R. Olinger | Chief People Services Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 132.87 per share. | 10 Mar 2026 | 509 | 7,859 (0%) | 0% | 132.9 | 67,631 | Class A Common Stock |
| Nelnet Inc (Class A) | Emily R. Olinger | Chief People Services Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.23 per share. | 10 Mar 2026 | 111 | 4,428 (0%) | 0% | 131.2 | 14,567 | Class A Common Stock |
| Nelnet Inc (Class A) | Emily R. Olinger | Chief People Services Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.24 per share. | 10 Mar 2026 | 50 | 4,378 (0%) | 0% | 131.2 | 6,562 | Class A Common Stock |
| Linde | Victoria E. Ossadnik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2026 | 473 | 473 | - | - | Restricted Stock Units | |
| Linde | Victoria E. Ossadnik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 470 | 0 | - | - | Restricted Stock Units | |
| Linde | Victoria E. Ossadnik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2026 | 470 | 3,805 (0%) | 0% | 0 | Ordinary Shares | |
| Linde | Victoria E. Ossadnik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 494.70 per share. | 09 Mar 2026 | 37 | 3,767 (0%) | 0% | 494.7 | 18,304 | Ordinary Shares |
| Enovis Corp | Oliver Engert | Chief Administrative Officer | Purchase of securities on an exchange or from another person at price $ 23.39 per share. | 06 Mar 2026 | 1,000 | 46,640 (0%) | 0% | 23.4 | 23,390 | Common stock, par value $0.001 |
| Enovis Corp | Oliver Engert | Chief Administrative Officer | Purchase of securities on an exchange or from another person at price $ 24.48 per share. | 06 Mar 2026 | 500 | 45,640 (0%) | 0% | 24.5 | 12,240 | Common stock, par value $0.001 |
| Columbia Fin Inc | Oliver Edward Lewis | SEVP & Head Commercial Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.06 per share. | 06 Mar 2026 | 392 | 27,336 (0%) | 0% | 18.1 | 7,080 | Common Stock |
| Enovis Corp | Oliver Engert | Chief Administrative Officer | Purchase of securities on an exchange or from another person at price $ 24.28 per share. | 06 Mar 2026 | 250 | 45,140 (0%) | 0% | 24.3 | 6,070 | Common stock, par value $0.001 |
| Burford Cap Ltd | Elizabeth O’Connell | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 156,287 | 425,470 | - | - | RSUs | |
| California Water Service Grp | Elissa Y. Ouyang | VP Facilities Fleet & Procure | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2026 | 900 | 15,611 (0%) | 0% | 0 | Common Stock | |
| California Water Service Grp | Elissa Y. Ouyang | VP Facilities Fleet & Procure | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.59 per share. | 05 Mar 2026 | 488 | 15,123 (0%) | 0% | 45.6 | 22,248 | Common Stock |
| California Water Service Grp | Elissa Y. Ouyang | VP Facilities Fleet & Procure | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.78 per share. | 05 Mar 2026 | 74 | 14,711 (0%) | 0% | 45.8 | 3,388 | Common Stock |
| California Water Service Grp | Elissa Y. Ouyang | VP Facilities Fleet & Procure | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.60 per share. | 05 Mar 2026 | 57 | 15,066 (0%) | 0% | 45.6 | 2,599 | Common Stock |
| Adaptive biotech Corp | Einterz Owen Katey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 15,625 | 88,254 (0%) | 0% | 0 | Common Stock | |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 208.80 per share. | 04 Mar 2026 | 3,413 | 21,662 (0%) | 0% | 208.8 | 712,621 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 207.91 per share. | 04 Mar 2026 | 2,457 | 25,075 (0%) | 0% | 207.9 | 510,823 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 1,607 | 0 | - | - | Employee Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.49 per share. | 04 Mar 2026 | 1,607 | 34,619 (0%) | 0% | 58.5 | 93,993 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 206.89 per share. | 04 Mar 2026 | 1,588 | 27,532 (0%) | 0% | 206.9 | 328,542 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 205.79 per share. | 04 Mar 2026 | 1,457 | 29,120 (0%) | 0% | 205.8 | 299,841 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 201.73 per share. | 04 Mar 2026 | 950 | 32,685 (0%) | 0% | 201.7 | 191,640 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 204.74 per share. | 04 Mar 2026 | 743 | 30,577 (0%) | 0% | 204.7 | 152,125 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 198.71 per share. | 04 Mar 2026 | 699 | 34,386 (0%) | 0% | 198.7 | 138,895 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 201.09 per share. | 04 Mar 2026 | 698 | 33,635 (0%) | 0% | 201.1 | 140,364 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 202.79 per share. | 04 Mar 2026 | 697 | 31,988 (0%) | 0% | 202.8 | 141,343 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 203.63 per share. | 04 Mar 2026 | 668 | 31,320 (0%) | 0% | 203.6 | 136,024 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 466 | 0 | - | - | Employee Stock Option (right to buy) | |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 80.72 per share. | 04 Mar 2026 | 466 | 35,085 (0%) | 0% | 80.7 | 37,616 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 200.08 per share. | 04 Mar 2026 | 53 | 34,333 (0%) | 0% | 200.1 | 10,604 | Common Stock |
| California Water Service Grp | Elissa Y. Ouyang | VP Facilities Fleet & Procure | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2026 | 1,650 | 15,084 (0%) | 0% | 0 | Common Stock | |
| Enovis Corp | Oliver Engert | Chief Administrative Officer | Purchase of securities on an exchange or from another person at price $ 24.77 per share. | 03 Mar 2026 | 1,000 | 44,640 (0%) | 0% | 24.8 | 24,770 | Common stock, par value $0.001 |
| California Water Service Grp | Elissa Y. Ouyang | VP Facilities Fleet & Procure | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.99 per share. | 03 Mar 2026 | 299 | 14,785 (0%) | 0% | 47.0 | 14,050 | Common Stock |
| Enovis Corp | Oliver Engert | Chief Administrative Officer | Purchase of securities on an exchange or from another person at price $ 25.10 per share. | 03 Mar 2026 | 250 | 44,890 (0%) | 0% | 25.1 | 6,275 | Common stock, par value $0.001 |
| Novavax Inc | Elaine O'Hara | EVP, Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 177,500 | 177,500 | - | - | 2026 Non-statutory Stock Option NQ | |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 23,527 | 23,527 | - | - | Employee Stock Option (right to buy) | |
| Columbia Fin Inc | Oliver Edward Lewis | SEVP & Head Commercial Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 20,000 | 20,000 | - | - | Stock Options (right to buy) | |
| Columbia Fin Inc | Oliver Edward Lewis | SEVP & Head Commercial Banking | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 11,772 | 11,772 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | George O. Elston | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Mar 2026 | 5,000 | 30,000 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | George O. Elston | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Mar 2026 | 5,000 | 87,818 (0%) | 0% | 0 | Common Stock | |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 4,933 | 37,945 (0%) | 0% | 0 | Common Stock | |
| Helen of Troy Ltd | Elena B. Otero | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 1,429 | 7,765 (0%) | 0% | 0 | Common Shares, Par value $0.10 per share | |
| Enovis Corp | Oliver Engert | Chief Administrative Officer | Purchase of securities on an exchange or from another person at price $ 25.50 per share. | 27 Feb 2026 | 1,000 | 43,640 (0%) | 0% | 25.5 | 25,500 | Common stock, par value $0.001 |
| Mereo Biopharma Grp PLC (ADR) | Anders Olof Adolf Ekblom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 133,560 | 133,560 | - | - | Deferred Restricted Stock Units | |
| Mereo Biopharma Grp PLC (ADR) | Anders Olof Adolf Ekblom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 66,000 | 66,000 | - | - | Share Options (Right to buy) | |
| Williams Companies | Eric J. Ormond | Senior Vice President | Grant, award, or other acquisition of securities at price $ 72.17 per share. | 19 Feb 2026 | 10,392 | 38,127 (0%) | 0% | 72.2 | 749,991 | Common Stock |
| Williams Companies | Eric J. Ormond | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 9,822 | 9,822 | - | - | Restricted Stock Units | |
| Cineverse Corp (Class A) | Erick Opeka | CSO and President | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 17 Feb 2026 | 30,000 | 224,146 (0%) | 0% | 2 | 60,000 | Class A Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2026 | 8,810 | 41,014 (0%) | 0% | 0 | Common Stock | |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2026 | 7,390 | 35,965 (0%) | 0% | 0 | Common Stock | |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 183.83 per share. | 14 Feb 2026 | 4,483 | 36,531 (0%) | 0% | 183.8 | 824,110 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 183.83 per share. | 14 Feb 2026 | 3,761 | 32,204 (0%) | 0% | 183.8 | 691,385 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 183.83 per share. | 14 Feb 2026 | 1,270 | 33,012 (0%) | 0% | 183.8 | 233,464 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 183.83 per share. | 14 Feb 2026 | 1,223 | 34,282 (0%) | 0% | 183.8 | 224,824 | Common Stock |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 183.83 per share. | 14 Feb 2026 | 1,026 | 35,505 (0%) | 0% | 183.8 | 188,610 | Common Stock |
| AT&T | Edward Oliver Gillespie | SEVP-Ext & Legislative Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 11,795 | 23,592 | - | - | Restricted Stock Units (2025) | |
| AT&T | Edward Oliver Gillespie | SEVP-Ext & Legislative Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 11,795 | 276,851 (0%) | 0% | - | Common Stock | |
| AT&T | Edward Oliver Gillespie | SEVP-Ext & Legislative Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.80 per share. | 13 Feb 2026 | 5,315 | 271,536 (0%) | 0% | 28.8 | 153,072 | Common Stock |